Login
Navigate Fool.com
Will PBYI beat
the market?

Puma Biotechnology Inc (NYSE: PBYI)

Community Rating: 1 Star: Ominous

58.98 -0.01 (-0.02%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $58.27
Previous Close $58.99
Daily Range $57.39 - $59.46
52-Week Range $33.70 - $143.65
Market Cap $1.8B
P/E Ratio -27.31
Dividend (Yield) $0.00 (0.0%)
Volume 348,030
Average Daily Volume 382,725
Current FY EPS -$2.83

How do you think PBYI
will perform against the market?

Top PBYI Bull/Bear Pitches

 

There are no pitches that meet the Top Bull criteria. Explain

If this upsets you, start recommending pitches here!

 

zzlangerhans (< 20)
Submitted December 9, 2013

I've had my share of faceplants with red thumbs on oncology stocks, so I certainly won't be following up this red thumb with an actual short. Nevertheless, I found the monster spike in Puma after the … More

0 Replies Reply Report this Post

News & Commentary Rss Feed

Should Puma Biotechnology Stock Be in Your Portfolio?

Shares of Puma Biotechnology have plummeted this year after being one of the strongest performers a year ago. Here's why this beaten down biotech belongs in your portfolio.

Thursday's ETF Movers: GDXJ, XBI

Upcoming Catalysts Could Drive Seven Biotech and Health Care Stocks Higher

3 Stocks Tumbling This Month: Clovis Oncology, Hyperion Therapeutics, and Puma Biotechnology

Puma Biotechnology (PBYI), Clovis Oncology (CLVS), and Hyperion Therapeutics (HPTX) all stumbled by more than 10% in June.

3 Stocks Crushed by the Market This Week

Good news for Wall Street didn't extend to every stock. Here are three of this week's biggest losers.

This Week in Biotech: A Trifecta of Disappointment Mars ASCO While Biogen Scores a Big Victory

Three disappointing studies highlight this past week's ASCO data while Biogen Idec and two other biotechs deliver positive regulatory news to investors.

Why Bebe Stores, Arctic Cat, and Puma Biotechnology Tumbled Today

Stocks were generally higher today, with major-market benchmarks hitting new record levels. Find out why these companies missed out.

Monday's ETF Movers: KRE, XBI

Why Puma Biotechnology Inc. Shares Were Creamed

Puma Biotechnology shares face a double whammy following the annual ASCO conferences. Find out what's next for Puma and shareholders.

Sector Update: Healthcare Shares Flat Pre-Market; ImmunoCelluar up 12% on Positive Data on Immunothe

Sector Update: Healthcare Shares Flat Pre-Market; ImmunoCelluar up 12% on Positive Data on Immunotherapeutic Vaccine

See More PBYI News...

Sector

Industry

Puma Biotechnology Inc (PBYI) Description

Puma Biotechnology Inc Website: http://www.pumabiotechnology.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks